Latest News

HUNTINGTON, W.Va. – A new clinical trial underway at Marshall University uses advanced medical device technology coupled with Computer-Aided Detection (CADe) systems, a form of artificial intelligence (AI), to reduce the risk of missed polyps, or lesions, during colonoscopy procedures. Gastroenterologists at the Marshall University Joan C. Edwards School of Medicine...
San Francisco, CA – Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator. The new Danaher-IGI Beacon for CRISPR Cures center will use genome...
CAMBRIDGE, Mass. – Biogen Inc. (Nasdaq: BIIB) today announced new research supporting the continued development of an investigational higher dose of SPINRAZA® (nusinersen) and additional data reinforcing the strength of SPINRAZA’s clinical profile in improving the lives of individuals with spinal muscular atrophy (SMA) over the long term. These data...